Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I think the most likely buyer has always been Novartis. Their IP portfolio for regenerative medicine is lacking and Mike Perry obviously is the common link having held multiple senior titles there and overlapping his time between Avita and Novartis.
Interesting. I wish Avita would use a credible U.S. firm to finance instead of a nothing shop like Bell Potter but I won't complain about them having extra cash or the dilution. Avita needs to focus on their footprint and investor base in the U.S. and get away from Australia.
If we were "splitting hairs" before, we are moving towards splitting already split hairs as the self-imposed deadlines near.
I've been thinking about the Shareholder letter and everything Lightwave has put in print lately, including Proto's comment from Karen. "We are talking to customers!!" (I think that was the quote) It sounds like she is trying to convey something...
There is a new focus from the company on how we are talking to customers and getting feedback. This is my own version of reading between the lines. If something will prevent samples from being finished this year it stems from these customer conversations. Lebby may be curtailing samples to the specific interests of different potential customers. This would not delay progress, probably accelerates it, but it would impact having all samples ready in 2018.
I will make an additional prediction, the company financing themselves in their normal dilutive manner while the shareprice is struggling will give the impression that testing is not going well and tensions will be the highest they've been in years. If you had asked me 6 months ago if this would happen I would say no because it should be common sense not raise at that time, but here we are.
Devices being sent out to potential customers for testing by year end most likely wouldn't produce any deal until Q1 of 2019.
I've noticed the board has turned somehow turned it into one event.
Smart tax sellers will know that selling at year end means rolling the dice on the 30 day buy back rule if they plan to jump back in.
Jim had nothing to do with finding that. I met the nice lab staff member Lebby hired who told Michael about that wonderful space that could be cheaply rented. He worked for the company who vacated it.
That would be tremendously well received by most long term U.S. shareholders.
The company needs someone who understands and cares about capital markets because it is obvious that we do not have that.
Lebby is CEO/CTO. We could use a solid CFO/COO in one.
The lower your share price, the more dilution, the lower your buyout or whatever you expect will happen.
Unfortunately, most of the people with enough stock to have a voice want everyone to smile and shake their hand when they see management face to face. Lightwave got away from the East coast and from the more critical and demanding investors.
Not really a surprise considering the company has removed or replaced everyone involved in Vancouver.
Sacrebleu! How could this company both develope, progress AND raise money from a credible source at the same time? It is not possible.
Avita is going to have to try harder if they want to meet Nasdaq's listening requirements organically.
Block sale from the cheap placements? We've seen one other large AH trade happen like that for Avita, when the rest of the Hunter Halls shares got taken.
Very good proto. Nice to have Karen handling inquiries because she knows what is going on at the company.
Perhaps you should do what I did. Spend several years making others aware that LPC is a terrible financing method, express desire to see betterment at the company. Realize that it will be at your own expense.
I saw the article you are talking about, that specifically references a woman being the CEO of the Colorado based company.
You're welcome, Walter. I was glad to get some clarity on this.
Splitting hairs, but I think they'll be ready to go out by EOY and in early 2019 being tested by other companies.
Wow, that is a major development. Thank you.
You are correct. I asked my question tactfully. I did quote the removed piece from the 10Q and asked if it was removed purposefully because of a delay. The response was No, it was not.
The information in the Shareholder letter is still correct.
Speculation on my part, but I doubt Lebby is the one writing, updating, issuing the 10Q.
Clarification on the 10q from Lebby and another bonus.
I sent an email to Dr. Lebby inquiring about the removal of the statement in the 10q possibly indicating a delay.
He responded no, that everything is still on schedule as indicated in the shareholder letter.
Also, Karen Liu has replaced Cordovano as IR. Investors should now direct inquiries to her. I was pleased to hear this as well. I'm looking forward to improvements in communication.
Prior to FDA approval, I know that the company kept itself out of the public eye in the U.S. because the FDA frowned upon Avita touting itself before a decision. This obviously doesn't stop most companies from doing so, but Avita was heavily reliant on government funding and support so they abided by it. It hasn't been very long but I know the company aspires to join the junior NASDAQ, they will need to do better with their investment community communication.
I will give them credit for one thing, they do a great job with their Twitter Feed. It is by far the best way to see what is going on with Avita.
That is great news for POETF. Seems that they too are aware that no communication with investor markets is required to be successful. Just look at their stock, up 3.5 cents today!
MGMT raised too much at lower levels in Australia and they seem unable to market themselves as an in investment in the U.S.
Mike Perry may be an asset behind the scenes, I was happy to see him take over, but his public presence is disappointing and shows a lack of understanding of what is required of a CEO at a public company.
Accipiterr, what has you expecting results on 3rd-degree burns?
tdeck, have you had much luck communicating with Dale Sander lately?
Lebby's Letter to Shareholders was released very close to the time when the 10Q was being compiled. Shareholder letter stated that. "We are happy to report that we are making excellent progress and are on track to achieve the goals we set out at our ASM in May 2018"
"Lightwave Plans Penetration"
Of markets. No longer will it only be of their long-term investors.
It very well could not have been PRd because Karen is now rectifying their PR system that sends investors news at inconsistent times or not at all.
I had a very productive exchange with Karen Liu last weekend. We should see less PR/IR mishaps going forward.
At the SHM that is what I was specifically told. In addition, Lebby will only provide samples to companies that agree to a rather short response time. About a month or less.
A pro-business administration just allowing business to occur. Probably alot to consider. Jobs, lack of interest here, the cost to taxpayers if the mine sits abandoned.
Agree.
That is the other issue they won't fix, every investor should get their PR at the same time. Not one by one. Even the most poorly run companies that I've followed disseminate their news in an orderly fashion.
I did check them first.
Neither of the email accounts that I have signed up for LWLG news received this PR. Really getting sick of Lightwaves Terrible IR.
As far as I know, Sears Auto Center is a profitable entity.
Possibly, depending on how favorable the debt/equity ratio is. All positive developments for NioCorp are also a reminder that they are years away from having a functioning mine. It's hard for the market to get really exited with a long timeline like that.
Of course but it seems to be a very favorable contract for NioCorp. Sorry if I overlooked it, is Traxys already marketing Sc or are they expanding their footprint? Since Traxys selected two sectors I would assume they already have customers.
I know some are surprised the stock didn't move up more, but investors were expecting a contract of some sort by now. It was priced in.
Lightwave doesn't keep anyone informed when they're raising money and that is the most likely reason. This, unfortunately, leaves most investors unnecessarily concerned.
I will speculate on some other issues. TerryH's family cleared his position and sent it tumbling. Marcelli spilled his Big Gulp on the million dollar machine and broke it. Someone got a sample and it had issues. Other trouble in the Lab. Tom was trying to back his giant pick up truck into the closest parking space, backed over a crucial lab member. Old investors finally hearing that Terry Turpin is no longer involved with the company.
(SOME OF THESE ARE JOKES)
We won't speculate on where our other company would be trading if they provided the same cold shoulder for the market.
I'm being serious. Lebby runs the company rather one-dimensionally. The science is his focus. Other important aspects of being public are ignored, aside from the clerical work Jim does. They're obviously capable of hiring competent people to handle important roles. (Karen Lui, lab staff, etc.) But not IR or someone who understands how to raise money and communicate with the investor markets?
We are at new 52 week lows during a time when Lightwave is doing better than it ever has in its existence. This is what mismanagement gets you.
I realize that Lebby is a savior for Lightwave and I'm glad he is the face of the company, I genuinely like him and vice-versa. I just wish he ran things like a CEO and not a CTO. Stock price does not interest him at all. This is not debatable. It hurts us and the company. I assume that part of the problem is so many are kissing up when they speak to him that he doesn't get a true impression of investor sentiment. He can do no wrong. He did get a taste at the SHM this year during the Q&A.
At the SHM Lebby gave the same style presentation he did the year prior, all science/device focus. In 2017 that was ok, he was the new CEO. This year he got backlash from angry investors wanting to hear about money, coverage, financing, stock price. You know, all the things investors actually give a damn about. Lebby seemed surprised and not prepared to deal with these upset people, Tom rushed up to grab the microphone eventually and calm things down. It was rather humorous.
I'm assuming this is an LPC sell down and will add to my position. Doesn't help the stock when all the good news lately has to be gleaned from slideshow presentations given to other people and explained to us by the few message board members who actually understand Photonics.
Lightwave needs to get it's shit together.